Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as C$4.17 and last traded at C$4.15, with a volume of 26439 shares changing hands. The stock had previously closed at C$3.99.
Medexus Pharmaceuticals Trading Up 3.8%
The firm has a 50-day moving average of C$3.67 and a 200-day moving average of C$3.12. The stock has a market capitalization of C$133.72 million, a price-to-earnings ratio of -207.00 and a beta of 0.57.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Recommended Stories
- Five stocks we like better than Medexus Pharmaceuticals
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
